Bioorthogonal probes for polo-like kinase 1 imaging and quantification

Angewandte Chemie - International Edition

Volumn 50, Issue 40, 2011, Pages 9378-9381

  Budin, Ghyslain ^a   Yang, Katherine S ^a   Reiner, Thomas ^a   Weissleder, Ralph ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cancer; cell cycle; cycloaddition; live cell imaging; polo like kinase

Indexed keywords

CANCER; CANCER CELL LINES; CELL CYCLE; COLOCALIZATION; EXPRESSION LEVELS; FLUORESCENT DYES; LIVE CELL; LIVE-CELL IMAGING; NUCLEAR PROTEINS; POLO-LIKE KINASE; PROTEIN TARGETS;

CELL CULTURE; CELLS; CYCLOADDITION; DISEASES; TISSUE;

ENZYMES;

4 (8 CYCLOPENTYL 7 ETHYL 5,6,7,8 TETRAHYDRO 5 METHYL 6 OXO 2 PTERIDINYLAMINO) 3 METHOXY N (1 METHYL 4 PIPERIDINYL)BENZAMIDE; CELL CYCLE PROTEIN; ENZYME INHIBITOR; FLUORESCENT DYE; ONCOPROTEIN; POLO LIKE KINASE 1; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE; PTERIDINE DERIVATIVE; RECOMBINANT PROTEIN; TEXAS RED; XANTHENE DERIVATIVE;

ARTICLE; CELL CYCLE G2 PHASE; CELL DIVISION; CELL NUCLEUS; CHEMISTRY; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; TUMOR CELL LINE;

CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; ENZYME INHIBITORS; FLUORESCENT DYES; G2 PHASE; HUMANS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PTERIDINES; RECOMBINANT PROTEINS; XANTHENES;

EID: 80053142652     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201103273     Document Type: Article

References (24)

1. D. M. Glover, I. M. Hagan, A. A. Tavares, Genes Dev. 1998, 12, 3777.
2. E. A. Nigg, Curr. Opin. Cell Biol. 1998, 10, 776.
3. B. C. van de Weerdt, R. H. Medema, Cell Cycle 2006, 5, 853.
4. A. K. Roshak, E. A. Capper, C. Imburgia, J. Fornwald, G. Scott, L. A. Marshall, Cell Signalling 2000, 12, 405.
5. F. Toyoshima-Morimoto, E. Taniguchi, E. Nishida, EMBO Rep. 2002, 3, 341.
6. N. Watanabe, H. Arai, Y. Nishihara, M. Taniguchi, N. Watanabe, T. Hunter, H. Osada, Proc. Natl. Acad. Sci. USA 2004, 101, 4419.
7. H. Nakajima, F. Toyoshima-Morimoto, E. Taniguchi, E. Nishida, J. Biol. Chem. 2003, 278, 25277.
8. F. Toyoshima-Morimoto, E. Taniguchi, N. Shinya, A. Iwamatsu, E. Nishida, Nature 2001, 410, 215.
9. M. Jackman, C. Lindon, E. A. Nigg, J. Pines, Nat. Cell Biol. 2003, 5, 143.
10. A. E. Elia, L. C. Cantley, M. B. Yaffe, Science 2003, 299, 1228.
11. A. E. Elia, P. Rellos, L. F. Haire, J. W. Chao, F. J. Ivins, K. Hoepker, D. Mohammad, L. C. Cantley, S. J. Smerdon, M. B. Yaffe, Cell 2003, 115, 83.
12. A. Hanisch, A. Wehner, E. A. Nigg, H. H. Sillje, Mol. Biol. Cell 2006, 17, 448.
13. D. M. Lowery, K. R. Clauser, M. Hjerrild, D. Lim, J. Alexander, K. Kishi, S. E. Ong, S. Gammeltoft, S. A. Carr, M. B. Yaffe, EMBO J. 2007, 26, 2262.
14. M. R. Smith, M. L. Wilson, R. Hamanaka, D. Chase, H. Kung, D. L. Longo, D. K. Ferris, Biochem. Biophys. Res. Commun. 1997, 234, 397.
15. F. Eckerdt, J. Yuan, K. Strebhardt, Oncogene 2005, 24, 267.
16. J. Yuan, A. Horlin, B. Hock, H. J. Stutte, H. Rubsamen-Waigmann, K. Strebhardt, Am. J. Pathol. 1997, 150, 1165.
17. K. Strebhardt, A. Ullrich, Nat. Rev. Cancer 2006, 6, 321.
18. M. Steegmaier, et al., Curr. Biol. 2007, 17, 316.
19. N. K. Devaraj, S. Hilderbrand, R. Upadhyay, R. Mazitschek, R. Weissleder, Angew. Chem. 2010, 122, 2931
20. Angew. Chem. Int. Ed. 2010, 49, 2869.
21. M. Kothe, D. Kohls, S. Low, R. Coli, G. R. Rennie, F. Feru, C. Kuhn, Y. H. Ding, Chem. Biol. Drug Des. 2007, 70, 540.
22. G. Munzert, M. Steegmaier, A. Baum, (Boehringer Ingelheim International GmbH), WO2006/018182A1, 2006.
23. L. Arnaud, J. Pines, E. A. Nigg, Chromosoma 1998, 107, 424.
24. B. L. Millard, M. Niepel, M. P. Menden, J. L. Muhlich, P. K. Sorger, Nat. Methods 2011, 8, 487.